MyFinsight
Home
Blog
About
Contact
Download
Download image
Comprehensive loss
-$79,560K
Unrealized gain (loss) on
marketable securities
$432K
Net loss
-$79,992K
Gain on sale of equity
method investment
$255,146K
Interest and other income
(expense), net
$43,733K
Change in fair value of
non-controlling equity...
$3,942K
Change in fair value of
derivative liabilities
$700K
Change in fair value of
contingent consideration...
-$180K
Net loss before
income taxes
-$79,992K
Total other income
(expense)
$303,701K
Loss from operations
-$383,693K
License and
collaboration revenue
$139,743K
Total operating
expenses
$523,436K
Research and development
$409,618K
General and
administrative
$113,818K
Back
Back
Income Statement
source: myfinsight.com
Beam Therapeutics Inc. (BEAM)
Beam Therapeutics Inc. (BEAM)